Sargeant JA, King JA, Yates T, Redman EL, et al. The effects of empagliflozin, dietary energy restriction, or both on appetite-regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: the SEESAW randomised, double-blind, placebo-controlled trial. Diabetes Obes Metab 2022 Apr 19. doi: 10.1111/dom.14721.
PMID: 35441435